Äú»¹ÔÚΪÖÐÒ©¶à×é·Ö·ÖÎö¶ø½¹ÂÇÂð£¿
Äú»¹ÔÚΪÖÐÒ©¸´ÔÓÑùÆ·Öеͺ¬Á¿µÄ×é·ÖÄÑÒÔ»ñµÃÓÐЧË鯬ÐÅÏ¢¶ø¿àÄÕÂð£¿
Äú»¹ÔÚÊÖ¶¯±à¼°üº¬ÁбíºÍÅųýÁÐ±í½øÐÐÖÊÆ×Êý¾Ý²É¼¯Âð£¿
À´¿´¿´AcquireXÖÇÄÜ»¯Êý¾Ý²É¼¯ÈçºÎ°ïÖúÄúÌáÉý¹¤×÷ЧÂÊ£¬¸æ±ð996£¡
ɽºÓ´ºÂú¾¡œìé䣬¼Ò¹ú»¶¾ÛÒÑÎÞí¦£¬2020Äê×¢¶¨ÊDz»Æ½·²µÄÒ»Äê¡£ÔÚÄê³õ¿¹»÷йÚÒßÇéµÄÕ½¶·ÖУ¬ÖÐÒ½Ò©ÊÇÆäÖÐÒ»´óÌØÉ«ºÍÁÁµã¡£ÖйúÖÊÆ×ѧ»áÀíÊ»áÀíʳ¤£¬ÄϾ©´óѧ»¯Ñ§·ÖÎö¿ÆÑ§Ñо¿ËùËù³¤³ÂºéԨԺʿÕâÑù˵£º“²»¹ÜÊÇÖÐÒ©»¹ÊÇÎ÷Ò©£¬¶¼ÊÇ»¯Ñ§ÎïÖÊ£¬µ«Ç°ÕßÊǶàÖֳɷֵÄ×éºÏ£¬¶øºóÕßÔòÊǵ¥Ò»µÄ£»ÕæÕýÖβ¡Æð×÷ÓõͼÊÇÒ©ÎïÔÚÌåÄÚ½øÐеÄÉú»¯·´Ó¦¡£ËùÒÔ£¬»¯Ñ§Ñо¿¶Ô·¢Õ¹½¡¿µÊÂÒµ·Ç³£ÖØÒª”¡£½üÄêÀ´Ëæ×ÅÖÊÆ×¼¼ÊõµÄ²»¶Ï·¢Õ¹£¬ÒºÏàÉ«Æ×-¸ß·Ö±æÖÊÆ×ÁªÓü¼Êõ£¨LC-HR MS£©ÒѳÉΪ·ÖÎöÖÐÒ©¸´ÔÓÌåϵ»¯Ñ§ÎïÖÊ»ù´¡×îÇ¿ÓÐÁ¦µÄ¹¤¾ß¡£
AcquireX×Ô¶¯»¯ÖÇÄÜ»¯Êý¾Ý²É¼¯
»¯ºÏÎïÖÊÆ×¼ø¶¨Ò»Ö±ÊÇÖÐÒ©Ñо¿µÄÆ¿¾±Ö®Ò»£¬Ä¿Ç°¼ø¶¨×îÐÐÖ®ÓÐЧµÄ°ì·¨¾ÍÊǽ¨Á¢±ê׼ƷÆ×ͼÊý¾Ý¿â£¬Í¨¹ýÆ×ͼ¶Ô±È¡¢ËéÆ¬È·Ö¤µÄ·½Ê½£¬¶Ôδ֪³É·Ö½øÐпìËÙ׼ȷµÄ¼ø¶¨¡£È»¶øÖÐÒ©Ñо¿µÄÑùÆ·ÓÉÓÚÆä³É·Ö¸´ÔÓ£¬Å¨¶È²»Ò»£¬»ùÖʱ³¾°¸ÉÈÅ´ó£¬ÔÚLC-MS ·ÖÎöʱÈçºÎ»ñµÃÖÚ¶àµÍº¬Á¿×é·ÖµÄ¶þ¼¶/¶à¼¶ÖÊÆ×Ë鯬ÐÅÏ¢Ò»Ö±ÊÇÖÊÆ×·ÖÎö¹¤×÷ÕßÃæÁÙµÄÌôÕ½¡£
ÔÚ2018 ÄêASMSÉÏ·¢²¼µÄС·Ö×ÓÖÕ¶ËÆì½¢»úOrbitrap ID-XÉÏ£¬ÎÒÃÇÊ×´ÎÒýÈëÁËAcquireX×Ô¶¯»¯ÖÇÄÜ»¯Êý¾Ý²É¼¯Ä£Ê½¡£ÕâÖÖÐÂÐ͵IJɼ¯Ä£Ê½²ÉÓÃÉî¶È»úÆ÷ѧϰ£¬×Ô¶¯µü´ú¸üÐÂÅųýºÍ°üº¬ÁÐ±í£¬´Ó¶ø²É¼¯µ½¸ü¶àÓÐÒâÒåµÄÖÊÆ×Êý¾Ý£¬ÉîÊÜÖÐÒ©Ñо¿ÕßÐÅÀµºÍϲ°®¡£

ͼ1. AcquireXÖÇÄÜ»¯Êý¾Ý²É¼¯Ä£Ê½¹¤×÷ÔÀí
ÔÚ½ñÄêOrbitrap ExplorisϵÁÐвúÆ·ÖУ¬ÎÒÃÇͬÑùÒýÈëÁËAcquireXµÄ²É¼¯Ä£Ê½£¬ÒÔ°ïÖúµ½¸ü¶àµÄ¿ÆÑй¤×÷ÕßÄÜʹÓô˹¦ÄܽøÐпÆÑ§Ñо¿¡£Ïà½ÏÓÚ´«Í³DDAģʽ£¬AcquireX ģʽ²É¼¯µ½µÄÓÐЧË鯬Æ×ͼÊýÁ¿´ó·ùÔö¼Ó£¬´Ó¶øÄÜÔö¼Óδ֪»¯ºÏÎï¼ø¶¨µÄ¸²¸Ç¶ÈºÍÖÃÐŶȣ¬¶Ô×î¾ßÌôÕ½µÄµÍ·á¶È¡¢¸ß¸´ÔÓÐÔÑùÆ·»ñµÃǰËùδÓеĽá¹û£¬ÊÊÓÃÓÚÖÐÒ©Ñо¿µÄ¸÷¸öÁìÓò£ºÈçÖÐÒ©¼°ÖƼÁ»¯Ñ§³É·ÖµÄ±íÕ÷¡¢ÖÐÒ©´úл×éѧÑо¿¡¢ÖÐÒ©ÖÊÁ¿¿ØÖÆÑо¿£¨·Ç·¨Ìí¼Ó£¬Å©Ò©²ÐÁôɸ²éµÈ£©¡¢¼°ÖÐÒ©ÌåÄÚ´úлÑо¿µÈ¸÷ÁìÓòµ±ÖС£

ͼ2. AcquireXÖÇÄÜ»¯Êý¾Ý²É¼¯Ä£Ê½ÐÔÄÜÌØµã
AcquireX×îÐÂÓ¦Óóɹû
½üÆÚ£¬ÈüĬ·ÉÉ«Æ×ÖÊÆ×С·Ö×ÓÖÊÆ×Ó¦ÓÃÍŶÓÓëÏÃÃÅ´óѧÎâ²Êʤ½ÌÊÚÍŶӡ¢¼°ÄϾ©Ò©Ã÷¿µµÂºÍMassDefect Technologies¹«Ë¾ÖìÃ÷É粩ʿÍŶÓÊ×´ÎÀûÓÃÁËAcquireX ÖÇÄÜ»¯Êý¾Ý²É¼¯Ä£Ê½Ñо¿ÁËÏû¿ÊÍèÖÎÁÆÌÇÄò²¡µÄÒ©Àí»úÖÆºÍÎïÖÊ»ù´¡£¬³É¹û·¢±íÔÚ“Pharmacological Research, IF=5.89”£¬ÌâΪ“Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes”¡£
Ñо¿ÍŶӽ«AcquireXÖÇÄÜ»¯Êý¾Ý²É¼¯¡¢Êý¾ÝÍÚ¾ò¡¢ÍøÂçÒ©Àíѧ¡¢¼ÆËã»ú¸¨Öú°Ð±ê´¹µöµÈ¼¼ÊõÏà½áºÏ£¬¿ª·¢³öÒ»Ì׸ßЧɸѡÏû¿ÊÍè½µÌǹ¦Ð§³É·Ö·½·¨¡£Ñ¡ÔñÁË5¸öÖ÷ÒªµÄÌåÄÚ±©Â¶³É·Ö(¸ð¸ùËØ¡¢´ó¶¹ÜÕÔª¡¢´Ìâ±ú»¨ËØ¡¢Îåζ×Ó¼×ËØºÍ¸ñÁб½ëå)×÷ΪÓÐЧµÄ½µÑªÌdzɷ֣¬ÍøÂçÒ©ÀíѧʵÑé½á¹û±íÃ÷£¬ÕâÎåÖֳɷֿÉÒÔ×÷ÓÃÓÚ²»Í¬Ò©Îï°Ðµã£¬ÈçPI3K, PTP1B, MAPK, AKT, TNF, and NF-kB¡£Ñо¿ÌáʾÕâÎåÖֳɷֿÉÄܲÎÓëµ÷½Ú-ϸ°û¹¦ÄÜ»ò±íÏÖÑ×Ö¢ÒÖÖÆÄÜÁ¦£¬´Ó¶à¸ö»·½Ú»º½â²¡ÀíÉúÀí¹ý³Ì¡£

ͼ3. Ïû¿ÊÍèÖÎÁÆÌÇÄò²¡µÄÒ©Àí»úÖÆºÍÎïÖÊ»ù´¡Ñо¿ÕûÌå·½°¸
´ËÍ⣬Õâ5ÖֳɷֵÄÒ©Àí×÷ÓÃÒÑÔÚÌÇÄò²¡°ßÂíÓãÄ£ÐÍÖеõ½ÑéÖ¤¡£°ßÂíÓãÄ£Ðͽá¹û±íÃ÷£¬²»º¬¸ñÁб½ëåµÄÖÐÒ©µ¥ÌåºÏ¼Á¾ßÓÐÓëÏû¿ÊÍèÏàËÆµÄ½µÑªÌÇ»îÐÔ¡£ËäÈ»¸ñÁб¾ëåµÄ»îÐÔÇ¿ÓÚÏû¿ÊÍ裬µ«Ïû¿ÊÍèµÄÖÐÒ©³É·ÖÎåζ×Ó¼×ËØµÄ½µÌÇЧ¹û×îºÃ¡£Òò´Ë£¬»ùÓÚÖÇÄÜ»¯Êý¾Ý²É¼¯µÄÖÊÆ×¼¼ÊõºÍ¼ÆËã»úÍøÂçÒ©Àíѧ£¬¿ÉΪÖÐÒ©µÄÎïÖÊ»ù´¡Ñо¿ºÍ´Ó×ÔÈ»×ÊÔ´ÖÐѰÕÒÏȵ¼»¯ºÏÎïÌṩ½è¼ø·½·¨¡£

ͼ4. ÖÐÒ©»îÐÔ×é·Ö¸ßЧɸ²é¼¼Êõ²ßÂÔ
ÈüĬ·É×÷ΪȫÇòÁìÏȵķÖÎöÒÇÆ÷¹«Ë¾£¬Ò»Ö±ÖÂÁ¦ÓÚΪ¿Í»§ÌṩÏȽøµÄÒÇÆ÷ºÍ³öÉ«µÄ½â¾ö·½°¸¡£ÔÚÖÐÒ©Ñо¿ÁìÓò£¬ÎÒÃÇÌṩ´ÓÑùƷǰ´¦Àí£¬µ½É«Æ×·ÖÀ룬µ½ÖÊÆ×¼ì²â£¬µ½ÖÐÒ©Êý¾Ý¿â¼°Êý¾Ý´¦ÀíÈí¼þµÄÈ«Ì×ÍêÕû½â¾ö·½°¸¡£Î´À´ÎÒÃÇÆÚ´ýÓë¸ü¶àµÄ¿Í»§Ò»ÆðºÏ×÷£¬ÎªÖÐÒ©µÄ¿ÆÑ§Ñо¿¹±Ï×Ò»·ÝÁ¦Á¿¡£

ͼ5. ÈüĬ·ÉÊÀ¶û¿Æ¼¼ÖÐÒ©/ÌìÈ»²úÎï·ÖÎö½â¾ö·½°¸
(ÔðÈα༣º½ðÀûÒÇÆ÷d)

